Showing 1 - 4 results of 4 for search 'I. N. Taran', query time: 0.01s Refine Results
  1. 1
    A BRIEF SUMMARY OF THE RESULTS OF THE 6TH WORLD SYMPOSIUM ON PULMONARY HYPERTENSION IN NICE IN 2018: VIEW OF A YOUNG SCIENTIST

    A BRIEF SUMMARY OF THE RESULTS OF THE 6TH WORLD SYMPOSIUM ON PULMONARY HYPERTENSION IN NICE IN 2018: VIEW OF A YOUNG SCIENTIST by I. N. Taran

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

    CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION by I. N. Taran, Z. S. Valieva, T. V. Martynyuk, I. Ye. Chazova

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    INNOVATION IN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: STIMULATOR OF SOLUBLE GYANYLATE CYCLASE - RIOCIGUAT

    INNOVATION IN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: STIMULATOR OF SOLUBLE GYANYLATE CYCLASE - RIOCIGUAT by I. N. Taran, T. V. Martynyuk, S. N. Nakonechnikov, I. Ye. Chazova

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CLINICAL CASE: OPPORTUNITY OF THERAPY OPTIMIZATION DUE TO TRANSITIONING FROM SILDENAFIL TO RIOCIGUAT IN PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION

    CLINICAL CASE: OPPORTUNITY OF THERAPY OPTIMIZATION DUE TO TRANSITIONING FROM SILDENAFIL TO RIOCIGUAT IN PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION by I. N. Taran, V. M. Paramonov, Z. S. Valieva, M. A. Saidova, S. N. Nakonechnikov, T. V. Martynyuk, I. Ye. Chazova

    Published 2016-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: